{"id":228357,"date":"2026-01-05T05:15:20","date_gmt":"2026-01-05T11:15:20","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/combination-therapy-for-burkitts-lymphoma-dramatically-improves-cure-rates-in-mice"},"modified":"2026-01-05T05:15:20","modified_gmt":"2026-01-05T11:15:20","slug":"combination-therapy-for-burkitts-lymphoma-dramatically-improves-cure-rates-in-mice","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/combination-therapy-for-burkitts-lymphoma-dramatically-improves-cure-rates-in-mice","title":{"rendered":"Combination therapy for Burkitt\u2019s lymphoma dramatically improves cure rates in mice"},"content":{"rendered":"

<\/a><\/p>\n

Burkitt\u2019s lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy\u2014often referred to as a \u201cliving drug\u201d and administered as a single dose\u2014has been approved for certain types of blood cancer, offering hope for a cure even in severe cases. However, its effectiveness against Burkitt\u2019s lymphoma has been limited. Moreover, developing drugs that directly target MYC\u2014the root cause of this cancer\u2014has proven challenging for decades.<\/p>\n

Recently, a study led by Dr. Hiroshi Kotani, Assistant Professor at Kanazawa University in collaboration with a scientist at Roswell Park Comprehensive Cancer Center in Buffalo, NY, U.S., revealed that a SUMOylation inhibitor can suppress MYC activity. Building on this finding, the research team investigated whether combining CAR-T therapy with the SUMOylation inhibitor<\/a> TAK-981 could improve outcomes for Burkitt\u2019s lymphoma. The research is published<\/a> in Signal Transduction and Targeted Therapy.<\/p>\n

The team first confirmed that the SUMOylation inhibitor<\/a> effectively slowed the growth of Burkitt\u2019s lymphoma cells and altered their signaling pathways. They then examined the inhibitor\u2019s effect on CAR-T cells<\/a> and discovered a dual role: While it initially activated the CAR-T cells in a way that could hinder long-term effectiveness, it also triggered a built-in \u201csafety brake\u201d mechanism. These insights suggested that using only a limited dose of the inhibitor could maximize the benefits of CAR-T therapy as a durable, living treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"

Burkitt\u2019s lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy\u2014often referred to as a \u201cliving drug\u201d and administered as a single dose\u2014has been approved for certain types of blood cancer, offering hope for [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-228357","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=228357"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228357\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=228357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=228357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=228357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}